QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.7 USD | -1.03% |
|
-3.22% | -8.74% |
| Apr. 11 | John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission | CI |
| Apr. 05 | Quest Diagnostics Receives Shareholder Proposal from John Chevedden | CI |
Presenter SpeechBrian Tanquilut (Analysts)All right. Good morning, and welcome to the third da...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
2024-04-23
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
127
USD
Average target price
142.1
USD
Spread / Average Target
+11.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.74% | 14.1B | |
| -12.53% | 86.47B | |
| +9.68% | 82.27B | |
| +11.06% | 29.43B | |
| -12.62% | 16.82B | |
| -5.06% | 15.89B | |
| +1.87% | 12.05B | |
| -30.00% | 12.01B | |
| +20.50% | 11.19B | |
| -4.03% | 11.09B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Transcript : Quest Diagnostics Incorporated Presents at 2022 Jefferies Global Healthcare Conference, Jun-10-2022 11
